2021
DOI: 10.15585/mmwr.mm7050a2
|View full text |Cite
|
Sign up to set email alerts
|

Notes from the Field: Mucormycosis Cases During the COVID-19 Pandemic — Honduras, May–September 2021

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 4 publications
0
12
0
Order By: Relevance
“…Added to this, the high morbidity of symptomatic infections by COVID- 19 [44] generates a population at high risk of infection by MM-producing fungi in Honduras. In 2021, an epidemiological follow-up was published by the Ministry of Health of Honduras with the support of the PAHO and the CDC of USA, of a group of 17 patients with MM from four geographically distant hospitals in Honduras [15]. 11 of those 17 cases were associated with COVID-19, 12 patients had underlying diabetes, and 2 had proliferative hematologic disorders.…”
Section: Discussionmentioning
confidence: 99%
“…Added to this, the high morbidity of symptomatic infections by COVID- 19 [44] generates a population at high risk of infection by MM-producing fungi in Honduras. In 2021, an epidemiological follow-up was published by the Ministry of Health of Honduras with the support of the PAHO and the CDC of USA, of a group of 17 patients with MM from four geographically distant hospitals in Honduras [15]. 11 of those 17 cases were associated with COVID-19, 12 patients had underlying diabetes, and 2 had proliferative hematologic disorders.…”
Section: Discussionmentioning
confidence: 99%
“…We read the article by Watanabe et al with interest wherein the authors performed a systematic review of literature on COVID-19-associated mucormycosis (CAM) and estimated the pooled mortality at 29% [1]. Unfortunately, the authors have missed several peer-reviewed articles published before January 20, 2022 [2][3][4][5]. These studies had a larger proportion of pulmonary mucormycosis [2,4], reported higher mortality (73-88%) [2,5], and including them might have yielded a different result.…”
Section: Sirmentioning
confidence: 99%
“…Unfortunately, the authors have missed several peer-reviewed articles published before January 20, 2022 [2][3][4][5]. These studies had a larger proportion of pulmonary mucormycosis [2,4], reported higher mortality (73-88%) [2,5], and including them might have yielded a different result. Danion et al reported 17 CAM cases from France with a mortality of 88% at twelve weeks.…”
Section: Sirmentioning
confidence: 99%
“…During the COVID-19 pandemic, the use of immunomodulatory drugs (e.g., systemic corticosteroids and tocilizumab) and COVID-19-induced immune dysregulation increased the risk of mucormycosis (9,10). Cases of COVID-19-associated mucormycosis (CAM) have been reported worldwide (11)(12)(13)(14)(15)(16)(17)(18)(19)(20), and have been mostly associated with underlying uncontrolled diabetes mellitus diseases. Nevertheless, cutaneous and soft-tissue mucormycosis has been observed in immunocompetent individuals (21,22), such as those induced by traumatic implantation of contaminated soil and water during tornadoes (23).…”
Section: Mucormycosis Is a Devastating Invasive Fungal Infection Pred...mentioning
confidence: 99%